rs11103502
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000093.5(COL5A1):c.1827+45G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.179 in 1,609,864 control chromosomes in the GnomAD database, including 27,540 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 2096 hom., cov: 33)
Exomes 𝑓: 0.18 ( 25444 hom. )
Consequence
COL5A1
NM_000093.5 intron
NM_000093.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.35
Publications
7 publications found
Genes affected
COL5A1 (HGNC:2209): (collagen type V alpha 1 chain) This gene encodes an alpha chain for one of the low abundance fibrillar collagens. Fibrillar collagen molecules are trimers that can be composed of one or more types of alpha chains. Type V collagen is found in tissues containing type I collagen and appears to regulate the assembly of heterotypic fibers composed of both type I and type V collagen. This gene product is closely related to type XI collagen and it is possible that the collagen chains of types V and XI constitute a single collagen type with tissue-specific chain combinations. The encoded procollagen protein occurs commonly as the heterotrimer pro-alpha1(V)-pro-alpha1(V)-pro-alpha2(V). Mutations in this gene are associated with Ehlers-Danlos syndrome, types I and II. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
COL5A1 Gene-Disease associations (from GenCC):
- Ehlers-Danlos syndromeInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Ehlers-Danlos syndrome, classic typeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, PanelApp Australia, Genomics England PanelApp
- Ehlers-Danlos syndrome, classic type, 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- arterial disorderInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BP6
Variant 9-134754371-G-A is Benign according to our data. Variant chr9-134754371-G-A is described in ClinVar as Benign. ClinVar VariationId is 255057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.331 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL5A1 | NM_000093.5 | c.1827+45G>A | intron_variant | Intron 16 of 65 | ENST00000371817.8 | NP_000084.3 | ||
| COL5A1 | NM_001278074.1 | c.1827+45G>A | intron_variant | Intron 16 of 65 | NP_001265003.1 | |||
| COL5A1 | XM_017014266.3 | c.1827+45G>A | intron_variant | Intron 16 of 64 | XP_016869755.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.154 AC: 23455AN: 152080Hom.: 2094 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
23455
AN:
152080
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.169 AC: 42062AN: 249332 AF XY: 0.170 show subpopulations
GnomAD2 exomes
AF:
AC:
42062
AN:
249332
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.182 AC: 265200AN: 1457666Hom.: 25444 Cov.: 32 AF XY: 0.181 AC XY: 131104AN XY: 725430 show subpopulations
GnomAD4 exome
AF:
AC:
265200
AN:
1457666
Hom.:
Cov.:
32
AF XY:
AC XY:
131104
AN XY:
725430
show subpopulations
African (AFR)
AF:
AC:
2811
AN:
33398
American (AMR)
AF:
AC:
4304
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
AC:
2813
AN:
26102
East Asian (EAS)
AF:
AC:
14077
AN:
39672
South Asian (SAS)
AF:
AC:
12375
AN:
86194
European-Finnish (FIN)
AF:
AC:
9893
AN:
52838
Middle Eastern (MID)
AF:
AC:
841
AN:
5748
European-Non Finnish (NFE)
AF:
AC:
207666
AN:
1108746
Other (OTH)
AF:
AC:
10420
AN:
60262
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
12050
24100
36151
48201
60251
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
7328
14656
21984
29312
36640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.154 AC: 23446AN: 152198Hom.: 2096 Cov.: 33 AF XY: 0.155 AC XY: 11551AN XY: 74404 show subpopulations
GnomAD4 genome
AF:
AC:
23446
AN:
152198
Hom.:
Cov.:
33
AF XY:
AC XY:
11551
AN XY:
74404
show subpopulations
African (AFR)
AF:
AC:
3630
AN:
41576
American (AMR)
AF:
AC:
1860
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
390
AN:
3472
East Asian (EAS)
AF:
AC:
1764
AN:
5128
South Asian (SAS)
AF:
AC:
645
AN:
4816
European-Finnish (FIN)
AF:
AC:
1996
AN:
10596
Middle Eastern (MID)
AF:
AC:
44
AN:
292
European-Non Finnish (NFE)
AF:
AC:
12485
AN:
67994
Other (OTH)
AF:
AC:
320
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
991
1982
2972
3963
4954
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
266
532
798
1064
1330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
625
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Fibromuscular dysplasia, multifocal Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Mar 15, 2022
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.